Annual report pursuant to Section 13 and 15(d)

Common Stock, Stock-Based Awards and Warrants (Tables)

v3.19.1
Common Stock, Stock-Based Awards and Warrants (Tables)
12 Months Ended
Dec. 31, 2018
Equity [Abstract]  
Schedule of Stock Options, Valuation Assumptions
The fair values of stock options issued were determined on the grant date using the Black-Scholes option pricing model and the following level 3 assumptions for the years ended December 31, 2018, 2017 and 2016, respectively:
 
2018
 
2017
 
2016
Common stock price on grant date
$
2.69

 
$
2.74

 
$
8.34

Expected life (in years)
4.75

 
4.75

 
3.91

Risk-free interest rate
2.76
%
 
2.26
%
 
1.15
%
Expected stock volatility
64
%
 
52
%
 
44
%
Expected dividend yield
0
%
 
0
%
 
0
%
Fair value of stock options granted
$
1.47

 
$
0.93

 
$
2.93

Schedule of Share-based Compensation, Stock Options, Activity
Stock option activity for the year ended December 31, 2018 is as follows:
 
Shares
(in thousands)
 
Weighted Average Exercise Price
 
Weighted Average Remaining Contractual Term (in years)
 
Aggregate Intrinsic Value
(in thousands)
Balance unexercised at January 1, 2018
7,167

 
$
8.69

 
2.31
 
$

Granted
1,205

 
$
2.69

 

 


Exercised

 
$

 

 

Forfeited
(3,100
)
 
$
9.68

 

 

Balance unexercised at December 31, 2018
5,272

 
$
6.73

 
3.34
 
$

Exercisable at December 31, 2018
3,040

 
$
8.71

 
2.26
 
$

Vested and expected to vest after December 31, 2018
5,272

 
$
6.73

 
3.34
 
$

Schedule of Share-based Compensation, Stock Options, by Exercise Price Range
The following is a summary of the Company’s stock options outstanding at December 31, 2018:
Range of Exercise Price
Number Outstanding
(in thousands)
 
Weighted Average Remaining Contractual Term (in years)
 
Weighted Average Exercise Price
 
Number Exercisable
(in thousands)
 
Weighted Average Exercise Price
$13.54 - $13.54
100

 
1.42
 
$
13.54

 
88

 
$
13.54

$12.90 - $13.26
528

 
0.98
 
$
13.06

 
519

 
$
13.06

$10.57 - $12.51
744

 
0.83
 
$
11.28

 
702

 
$
11.22

$6.34 - $9.25
634

 
2.68
 
$
8.98

 
461

 
$
8.99

$6.22 - $6.22
1,000

 
2.67
 
$
6.22

 
747

 
$
6.22

$6.18 - $6.18
104

 
2.49
 
$
6.18

 
65

 
$
6.18

$3.21 - $3.21
926

 
5.27
 
$
3.21

 
434

 
$
3.21

$2.92 - $2.92
190

 
5.41
 
$
2.92

 
5

 
$
2.92

$2.65 - $2.65
960

 
5.47
 
$
2.65

 
9

 
$
2.65

$2.35 - $2.50
86

 
6.13
 
$
2.47

 
10

 
$
2.50

 
5,272

 
3.34
 
$
6.73

 
3,040

 
$
8.71

Schedule of Share-based Compensation, Restricted Stock and Restricted Stock Units Activity
RSU activity during the year ended December 31, 2018 was as follows:
 
Shares (in thousands)
 
Weighted Average Grant Date Fair Value
 
Aggregate Intrinsic Value (in thousands)
Balance nonvested at January 1, 2018
4,697

 
$
3.53

 
$
10,757

Granted
3,392

 
2.65
 
 
Vested
(1,325
)
 
3.61
 
 
Forfeited
(852
)
 
3.42
 
 
Balance nonvested at December 31, 2018
5,913

 
3.03
 
13,185

Vested and expected to vest at December 31, 2018
5,891

 
$
3.02

 
$
13,138

Schedule of Share-based Compensation Expense Allocation
Stock-based compensation expense related to all employee and, where applicable, non-employee stock-based awards was as follows for the years ended December 31, 2018, 2017 and 2016 (in thousands):
 
Year Ended December 31,
 
2018
 
2017
 
2016
Consolidated Statement of Operations Classification:
 
 
 
 
 
Cost of sales
$
547

 
$
300

 
$
313

Sales and marketing
498

 
423

 
629

Product development
753

 
634

 
994

General and administrative
11,019

 
6,228

 
8,811

Total
$
12,817

 
$
7,585

 
$
10,747


Schedule of Share-based Compensation, Warrants, Activity
The following is a summary of Public SPAC Warrants for the year ended December 31, 2018:
 
Number of Warrants (in thousands)
 
Weighted Average Exercise price
 
Weighted Average Remaining Contractual Term (in years)
Outstanding at January 1, 2018
6,173

 
$
11.50

 
0.09
Expired
(6,173
)
 

 
 
Outstanding and exercisable at December 31, 2018

 
$